Medical Health & Life Science Research News

Explore Global patient monitoring devices market that is expected to be worth $22.2 billion by 2018

The patient monitoring devices market is divided into nine major segments, namely, hemodynamic, neurology, cardiac, respiratory, fetal and neonatal, multiparameter, remote patient monitors, temperature, and weight management monitors. In 2013 cardiac monitoring device segment was the leading market segment. Under this segment the Electrocardiograph (ECG) sub-segment contributed to the maximum share of the cardiac monitoring market.

- Advertising -

The “Patient Monitoring Device/ Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Multiparameter, Remote, Weight, Temperature), End-user (Hospitals, Home) - Global Forecast to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global patient monitoring devices market along with the estimates and forecasts of the revenue and share analysis.

Browse 234 market data Tables and 47 Figures spread through 494 Pages and in-depth TOC on "Patient Monitoring Device Market"

The global patient monitoring devices market is estimated to reach $22,174 million by 2018 at a CAGR of 5.5% during the forecast period (2013–2018). The factors driving this market include increasing geriatric population, rising incidences of lifestyle diseases, home and remote monitoring, ease-of-use, and portability of devices expanding point-of-care monitoring devices. The factors restraining this market include economic downturn and saturation in developed countries and unstable reimbursement regulations.

- Advertising -

The electroencephalograph (EEG) monitoring device under neurological device segment will be the fastest growing segment by 2018. The major factors driving the growth of this segment are rise in the population size of the patients affected by neurodegenerative diseases. Eventually, rise in the awareness regarding the neurodegenerative diseases and the use of wireless neuromonitoring and remote patient monitoring systems will further propel the growth of this segment.

North America commanded the largest share in the patient monitoring devices market in 2013 and is expected to grow from 2013 to 2018, at a CAGR of more than 5.0%. The primary growth driver for North America is the expanding population size of the elderly and the mounting lifestyle diseases. Europe accounted for the second largest market share in 2013; however, in the forecast period the growth of this region will be slow. APAC, on the other hand, will be the main focus of the market in the coming five years that will register high growth rates for all the segments. Vast population sizes of countries such as India and China and improved purchasing power of the rising middle class will drive the growth.

The key players in the patient monitoring devices market are Abbott Laboratories (U.S), Covidien (Ireland), Drager Medical GmbH (Germany), GE Healthcare (U.K.), Johnson & Johnson Inc. (U.S), Masimo Corporation (U.S), Mindray Medical (China), Mortara Instrument Inc. (U.S.), Natus (U.S.), Nihon Kohden (Japan), Nonin Medical (U.S), Omron Healthcare (Japan), Philips Healthcare (Netherlands), Roche Diagnostics Limited (Switzerland), and Welch Allyn (U.S.).

Speak to Analyst:

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
This email address is being protected from spambots. You need JavaScript enabled to view it.